Condition: Acute Lymphoid Leukemia · Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
This is a multi-center, phase 2A exploratory study of feasibility and effectiveness of Inotuzumab Ozagomicin in adult patients with Acute Lymphoid Leukemia (ALL) with positive minimal residual disease before any hematopoietic stem cell transplantation. The study is divided in two cohorts; cohort 1 will enroll 38 Ph+ patients, cohort 2 will enroll 38 Ph- patients, as defined with statistical analysis. The two cohorts will have the same treatment, with the exception of short term and long term maintenance.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona- Sod Clinica Ematologica | Ancona, Italy | — |
| Area Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia | Ascoli Piceno, Italy | — |
| Asst Papa Giovanni Xxiii - Ospedale Di Bergamo - Sc Ematologia | Bergamo, Italy | — |
| Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia | Bologna, Italy | — |
| As Dell'Alto Adige, Ospedale Centrale Di Bolzano - Ematologia E Centro Trapianto Midollo Osseo | Bolzano, Italy | — |
| Asst Degli Spedali Civili Di Brescia - Uo Ematologia | Brescia, Italy | — |
| Aso S. Croce E Carle - Cuneo - Sc Ematologia | Cuneo, Italy | — |
| Irccs Aou San Martino - Genova - Uo Clinica Ematologica | Genova, Italy | — |
| Asl Lecce, Ospedale 'V. Fazzi' - Uo Ematologia | Lecce, Italy | — |
| I.R.S.T. Srl Irccs - Meldola - Sc Oncologia Medica | Meldola, Italy | — |
| Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia | Mestre, Italy | — |
| Asst Grande Ospedale Metropolitano Niguarda - Milano - Sc Ematologia | Milan, Italy | — |
+ 18 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.